Status:

COMPLETED

Clinical Evaluation of a Novel Incisional NPWT System

Lead Sponsor:

Aatru Medical LLC

Collaborating Sponsors:

NAMSA

Conditions:

Surgical Wound

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

A study of the first clinical use in humans of a novel NPWT system (npSIMS) to assess the suitability, safety and efficacy of the system for the management of closed surgical wounds

Detailed Description

The purpose of this investigation is to test the functionality of a novel, non-electric NPWT device: npSIMS (negative pressure Surgical Incision Management System) from Aatru Medical LLC (Ohio, USA) w...

Eligibility Criteria

Inclusion

  • 1\. Participant is male or female ≥ 18 years of age 2. Participant will undergo an elective sternotomy, thoracotomy, caesarean section (C-section) or skin surgery incision with closure by sutures or staples 3. Participant will undergo a surgical procedure resulting in a closed approximately linear incision between 5 cm and 13 cm in length inclusive so that the npSIMS dressing covers the wound with a minimum of 1 cm overlap at each end 4. Participant is willing and able to take part in the study and provide written informed consent.
  • \-

Exclusion

  • Participants will undergo post-surgical radiotherapy or chemotherapy
  • Participants who, in the opinion of the Investigator, have an existing health condition that would compromise their participation and follow-up in this study
  • Participant will undergo emergency surgery
  • Participant is sensitive to or known to have allergies to silicone/acrylic adhesives
  • Participant has malignancy in the wound bed or margins of the wound
  • Participant has wound with confirmed and untreated osteomyelitis
  • Participant has wound with non-enteric and unexplored fistulas
  • Participant has wound with necrotic tissue with eschar present
  • Participant has exposed arteries, veins, nerves or organs
  • Participant has exposed anastomotic sites

Key Trial Info

Start Date :

January 26 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 16 2025

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT04488666

Start Date

January 26 2021

End Date

June 16 2025

Last Update

July 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Middlemore Clinical Trials

Auckland, New Zealand